Department of Pathology Vice-Chair for Science Comments on New Embryonic Stem-Cell Policy

The Vice Chair of Science in the Department of Pathology and the Dr. Louis A. Schneider Professor of Molecular Pathology and Professor of Microbiology, David E. Levy, Ph.D., offered his perspective on President Barack Obama's decision to revert the ban on stem-cell funding for a news report by WCBS New York on March 9, 2009. In the news feature Dr. Levy noted that stem cells provide a "very promising road to better understanding human disease and potentially very innovative treatments." He continued, "there is a huge amount of potential but we don't know when or how that will be realized... what we do know is that if we can't do the research, if we can't do the basic investigation, we can never translate that into therapies for human disease."

A video of the news broadcast can be viewed on the WCBS 2 New York web site.

Dr. Levy was also interviewed by WNYC New York on the same topic.